This is the first case report exploring the modification of interleukin 17/β-defensin-2 in a patient with periodontitis or autoimmunity, showing the importance and effect of non-surgical therapy on modifications of the immune response at the molecular level. This evidence concerns the gene IL17A and periodontitis.